ProfileGDS5678 / 1444212_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 54% 52% 54% 52% 53% 56% 56% 53% 53% 53% 53% 53% 53% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3897154
GSM967853U87-EV human glioblastoma xenograft - Control 23.2740852
GSM967854U87-EV human glioblastoma xenograft - Control 33.3548754
GSM967855U87-EV human glioblastoma xenograft - Control 43.2049152
GSM967856U87-EV human glioblastoma xenograft - Control 53.2533953
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5155556
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4954456
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2859653
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2673153
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2945453
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2887953
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2806353
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3171853
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.303253